NeuroSense Therapeutics Ltd. Increase (Decrease) in Other Current Assets
NeuroSense Therapeutics Ltd. (NRSN) reported Increase (Decrease) in Other Current Assets of $753.00 thousand for the 12-month period ending 2024-12-31, per its 20-F filed 2025-04-07.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherCurrentAssets · last filed 2025-04-07
| Period end | Increase (Decrease) in Other Current Assets 6 month | Increase (Decrease) in Other Current Assets 12 month |
|---|---|---|
| 2024-12-31 | $753.00K 20-F · filed 2025-04-07 | |
| 2024-06-30 | $140.00K 6-K · filed 2024-09-30 | |
| 2023-12-31 | -$19.00K 20-F · filed 2025-04-07 | |
| 2023-06-30 | $179.00K 6-K · filed 2024-09-30 | |
| 2022-12-31 | -$55.00K 20-F · filed 2025-04-07 | |
| 2021-12-31 | $204.00K 6-K · filed 2024-06-17 |